Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Aug 2026 for Travere Therapeutics, Inc., €268k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Gary A Lyons: trading record in brief
Our data holds just one disclosure by Gary A Lyons, dated 17 August 2026, reporting a transaction worth €268k in Travere Therapeutics, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gary A Lyons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 5,000 shares@ US$62.140.0055% mcap100.0% of flowCommonSEC144:0001950047-26-008242
1 of 1 declaration
